Azenta, Inc. (NASDAQ: AZTA)

Azenta, Inc. is a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The company leverages its precision automation and cryogenics capabilities to develop and provide solutions for automated ultra-cold storage, supporting customers from research and clinical development to commercialization. Azenta's expertise in sample integrity and its broad portfolio of products and services cater to every stage of the life cycle of samples, including procurement, automated storage systems, genomic services, and a multitude of sample consumables, informatics, and data software, along with sample repository services. The company operates in North America, Asia, and Europe, with approximately 3,000 employees worldwide and sales in approximately 95 countries.

Azenta generates revenue through its comprehensive portfolio of products and services designed to address the needs of the life sciences industry. The company's primary offerings include automated storage systems, cryogenic systems, genomic services, and a range of consumables and instruments. These products and services are utilized by a diverse customer base that includes top pharmaceutical and biotechnology companies, advanced research hospitals performing clinical research and therapy development, biotech startups, academic institutions, and government institutions. The company's revenue streams are further bolstered by its expertise in sample management and genomic services, which help customers bring impactful therapies to market faster.

• Sample Management Solutions: This segment operates as a single business unit offering end-to-end sample management products and services. Key offerings include Sample Repository Services (SRS) and Core Products, which encompass Automated Stores, Cryogenic Systems, Automated Sample Tubes, Consumables and Instruments, and Controlled Rate Thawing Devices. The SRS services include on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery, business continuity, and project management and consulting. The Automated Stores product line features stand-alone systems capable of storing over 20 million samples in temperature ranges from ambient to -80°C, with high throughput and optimized storage capabilities. Cryogenic Systems provide long-term cryogenic storage with accurate record-keeping and dependable temperature control. Automated Sample Tubes include a range of automation-friendly storage tubes with various coding options. Consumables and Instruments cover a wide range of products used for storage and handling of samples in various temperature environments. Controlled Rate Thawing Devices are designed for automated thawing of plasma, blood, stem cells, and applications in cell and gene therapy. This segment caters to customers needing comprehensive sample management solutions throughout the lifecycle of samples, providing complete end-to-end "cold chain of custody" capabilities.

• Multiomics: This segment operates as a single business unit offering genomic and other sample analysis services. Key offerings include gene sequencing, gene synthesis, and related services. The genomic services business provides Next-Generation sequencing (NGS), Sanger sequencing, gene synthesis, bioinformatics, and good laboratory practices (GLP) regulatory services. These services enable the expanding research and development of gene-based healthcare discoveries and therapies. The segment also offers unique solutions for key markets such as cell and gene therapy, antibody development, and biomarker discovery. This segment caters to customers requiring advanced genomic services to support their research and development activities.

Azenta holds a strong position within the life sciences industry, competing with key players such as Hamilton Company and Liconic AG in the Sample Management Solutions segment, and BGI Genomics Co., Ltd., Eurofins Scientific S.E., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., Novogene Co., Ltd., and Twist Bioscience Corporation in the Multiomics segment. The company's competitive advantages include its global footprint, leadership positions, and a unique portfolio of products and services that address the critical needs of sample integrity and management. Azenta's expertise in precision automation and cryogenics, combined with its strategic acquisitions and internal investments, enables it to accelerate time to market for its life sciences solutions.

Azenta serves a broad range of customers within the life sciences industry, including top pharmaceutical and biotechnology companies, advanced research hospitals, biotech startups, academic institutions, and government institutions. The company's customer base spans approximately 14,000 customers globally, positioning it well to expand its reach and impact in the life sciences market.